Prior research has documented that CD4 memory T cells may inhibit the progression of tumors by upregulating the proliferative ability of CD8T cells, which differentiate into effector cells following their migration into tumor-associated tissues (Crouse et al., 2015). This evidence concerns the gene CD4 and neoplasm.